Author: Ken Dropiewski

Karoo Health Appoints Industry Leader as Chief Operating Officer and Accelerates Mission to Improve the Lives of Every Cardiac Patient in America

Industry Leader Chentelle Lane Joins as COO; Company Partners to Power Leading Cardiology Networks in Southwest ALBUQUERQUE, N.M., Oct. 19, 2022 /PRNewswire/ — Karoo Health, the leader in end-to-end, tech-enabled, value-based cardiac care, announced today the hiring of industry veteran Chentelle Lane as COO. Lane will help guide the company’s business and operating strategy, including […]

NeoChord Announces Positive 1-year Follow-Up Data with Transcatheter NeXuS System for Mitral Chordal Repair Using Multiple Chords to a Single Anchor

ST. LOUIS PARK, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company, is leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation with more than a decade of commercial experience in treating over 1,800 patients globally with the transapical […]

HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction

Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista SOUTHLAKE, Texas, Oct. 19, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making […]

AccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch

The two leading innovative companies have announced a landmark agreement to equip Mawi’s new cardiac monitoring watch with AccurKardia’s automated ECG analytics NEW YORK & LONDON–(BUSINESS WIRE)–AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, announced today it will collaborate with Mawi, a medtech provider of medical […]

Vivasc Therapeutics Inc. Receives Its Second NIH Phase I STTR Grant With the Goal of Reversing the Molecular Causes of Heart Failure

This approach may be a paradigm shift in patient care PITTSBURGH–(BUSINESS WIRE)–Vivasc Therapeutics Inc. is pleased to announce it has initiated its second NIH Phase I STTR research grant (Award Number R41HL164212), in conjunction with Georgetown University. This work is supported by the NIH National Heart, Lung, and Blood Institute, […]

GE Healthcare and AMC Health to Partner in Remote Patient Monitoring to Provide Patients with Chronic and Post-Acute Care in the Home

CHICAGO & NEW YORK–(BUSINESS WIRE)–GE Healthcare and AMC Health today announced a collaboration that allows clinicians to offer Remote Patient Monitoring (RPM) as a virtual care solution that extends patient care outside the hospital to the home environment. The combination of GE Healthcare’s acute patient monitoring capabilities in the hospital […]

Treatment of Severe Heart Failure – AI: FineHeart Awarded €2.5 million Grant Under the Prestigious EIC Accelerator Program, the First Part of Blended Financing of up to €17.5 Million for the Development and Clinical Trials of the ICOMS FLOWMAKER®

BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced that it had been awarded a €2.5 million grant by the European Commission […]

Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology

MIAMI LAKES, Fla., Oct. 18, 2022 /PRNewswire/ — Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies, today announced its acquisition, subject to customary closing conditions including regulatory approvals, of MedAlliance, a Switzerland-based company at the forefront of transformative drug-eluting balloons. By acquiring MedAlliance, Cordis has the potential to […]

RhythMedix® Expands Monitoring Capabilities of Its RhythmStar® System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity

Strategic addition of Extended Wear Holter monitoring modality enhances portfolio offering and positions company for accelerated growth MOUNT LAUREL, N.J., Oct. 18, 2022 /PRNewswire/ — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms, today announced expanded modalities for its RhythmStar® System (RhythmStar). The addition of long-term continuous electrocardiogram (ECG) monitoring […]